American Society of Clinical Oncology (ASCO)

Abstract titles for #ASCOBT24 are now available! If you want to stay at the forefront of innovation that is shaping clinical cancer care today, preview the high-impact science that will take center stage in Yokohama, Japan this August. Registration is still open, so secure your spot today. View abstract titles: https://brnw.ch/21wKYB2

Don't miss out on the innovative therapies and technological breakthroughs that will be presented at our one-of-a-kind global meeting in Yokohama, Japan! LAST CHANCE to SAVE—early registration for #ASCOBT24 ends June 26 at 11:59 PM ET! Register and reserve your hotel here: https://brnw.ch/21wKVz6

In a new op-ed from Physician's Weekly, Memorial Cancer Institute’s Dr. Luis E Raez and Tennessee Oncology’s Dr. Natalie Dickson detail the importance of quality care delivery, and how their participation in the ASCO Certified pilot program helped them to provide even better care for patients. “We were gratified by the certifications we achieved by looking beyond our own institutions. But the greatest pay-off was discovering better ways to serve our patients.” Read more: https://brnw.ch/21wKRLc

2025 ASCO Special Awards nominations are open until July 15. ASCO members can earn up to 2 FASCO points by submitting a nomination. Submit your nominations now: https://brnw.ch/21wKOT2

Our draft guideline, Treatment of Stage I-III Squamous Cell Anal Carcinoma, is now available for open comment. Submit feedback to us by July 1. https://brnw.ch/21wKNFx

We're pleased to welcome our 2024 #SummerIntern cohort who will support ASCO across various departments and project areas over the next 10 weeks. We look forward to your contributions and the great things that you'll accomplish!

🎉 We congratulate the participants selected for the 2024 International Development & Education Award (IDEA) and IDEA in Palliative Care (IDEA-PC) programs, which provide support for early-career oncologists in low- and middle-income countries (LMICs) to learn from and collaborate with our more senior members. The early-career oncologists receiving the 2024 IDEA and IDEA-PC are: ◾Mariami Abuladze, MD, PhD, Todua Clinic (Georgia) ◾HebatAllah Ahmed, MD, PhD, MSc, Assuit University (Egypt) ◾Haimanot Kasahun Alemu, MD, Saint Paul’s Hospital Millennium Medical College (Ethiopia) ◾Emmanuella Amoako, MD, Yemaachi Biotech (Ghana) ◾Hatice Bolek, MD, Ankara University (Turkey) ◾Matheus de Oliveira Andrade, MD, Universidade de Sao Paulo Instituto do Cancer do Estado de Sao Paulo (Brazil) ◾Khalid El Bairi, MD, Mohammed VI University Hospital (Morocco) ◾Vivek Ghosh, MD, MBBS, Birat Medical College Teaching Hospital (Nepal) ◾David Dai-Wee Lee, FRCR, MMEd, MBBS, University of Malaya Medical Center (Malaysia) ◾Kinjal Shankar Majumdar, MBBS, MS, MCh, Kasturba Medical College, Manipal Academy of Higher Education (India) ◾Long Nguyen, MD, MSc, Vietnam National Cancer Hospital (Vietnam) ◾Abeid Omar, MD, Kenyatta University Teaching Referral and Research Hospital (Kenya) ◾Mary Antonette Ong, MD, Philippine Society of Medical Oncology (Philippines) ◾Rolex Orcel, MD, Mirebalais University Hospital (Haiti) ◾Mariem Saadi, MD, Abderrahmen Mami Hospital (Tunisia) ◾Adekunle Emmanuel Sajo, MBBS, MPhil, University of Pretoria (South Africa) ◾Amalya Sargsyan, MD, MSc, Immune Oncology Research Institute (Armenia) ◾Aigul Semetei kyzy, MD, International Higher School of Medicine (Kyrgyzstan) ◾Karishma Sharma, MRCP, Aga Khan University Hospital (Kenya) ◾Ramesh Shrestha, MBBS, MS, BP Koirala Institute of Health Sciences (Nepal) ◾Lily Gloria Tagoe, MBChB, Korle Bu Teaching Hospital (Ghana) ◾Ghazal Tansir, MD, DM, MBBS, All India Institute of Medical Sciences (AIIMS) (India) ◾Tawasapon Thambamroong, MD, Phramongkutklao Hospital (Thailand) ◾Sofia Vidaurre Mendes, MD, Oncologia D`Or (Brazil) Both the IDEA and IDEA-PC programs are 10-day, in-person experiences that kick off shortly before the ASCO Annual Meeting. At the meeting's conclusion, the IDEA and IDEA-PC program members travel to their mentors’ respective institutions to spend several days learning alongside them. For the remainder of the year, the awardees can reach out to their mentors with questions. Upon completing the program, IDEA-PC recipients are expected to share the knowledge and training they received with colleagues in their home countries. Applications open soon for the 2025 program; learn more ➡️ https://lnkd.in/ee6dYZyf

We join the oncology community in mourning the loss of translational research pioneer V. Craig Jordan, CMG, OBE, PhD, DSc, FMedSci, on June 9, 2024. Read more: https://brnw.ch/21wKJ4l

Though there has been increased interest in using patient-reported outcomes, or PROs, as part of routine cancer care, barriers at the patient, clinician, and administrative levels have limited their implementation. Patient buy-in requires asking relevant and clinically useful questions, being sensitive to patient burden, and providing accessible options for PRO measure completion. Clinicians also experience their own barriers to PRO use. Traditional workflows require modifications to integrate PROs with clinic notes, laboratory results, and imaging findings. Workflows must present PRO data so that clinic discussions can focus on patients’ most relevant issues and support documentation requirements. As a result of these barriers, there is no one-size-fits-all PRO system. Each system must be adapted to the intended goals and resources available. For ASCO Daily News, a new expert editorial examines the potential for PRO use and the challenges involved: https://brnw.ch/21wKIXL

A key component to providing care is looking at a patient and their family holistically, which includes examining and intervening on patients’ behavioral health needs. ASCO’s Vice President of Care Delivery, Dr. Stephen Grubbs joins Dr. Sea Chen on the AMA Ed Hub podcast Steps Forward to discuss methods to integrate behavioral into oncology care. Listen now! Spotify: https://brnw.ch/21wKH3B Apple: https://brnw.ch/21wKH3A